Isolated tumor cells and micrometastases in regional lymph nodes in stage I to II endometrial cancer |
| |
Authors: | Yukiharu Todo Hidenori Kato Kazuhira Okamoto Shinichiro Minobe Katsushige Yamashiro Noriaki Sakuragi |
| |
Affiliation: | 1.Division of Gynecologic Oncology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.;2.Division of Pathology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.;3.Department of Obstetrics and Gynecology, Hokkaido University School of Medicine, Sapporo, Japan. |
| |
Abstract: | ObjectiveThe aim of this study was to clarify the clinical significance of isolated tumor cells (ITCs) or micrometastasis (MM) in regional lymph nodes in patients with International Federation of Gynecology and Obstetrics (FIGO) stage I to II endometrial cancer.MethodsIn this study, a series of 63 patients with FIGO stage I to II were included, who had at least one of the following risk factors for recurrence: G3 endometrioid/serous/clear cell adenocarcinomas, deep myometrial invasion, cervical involvement, lympho-vascular space invasion, and positive peritoneal cytology. These cases were classified as intermediate-risk endometrial cancer. Ultrastaging by multiple slicing, staining with hematoxylin and eosin and cytokeratin, and microscopic examination was performed on regional lymph nodes that had been diagnosed as negative for metastases.ResultsAmong 61 patients in whom paraffin-embedded block was available, ITC/MM was identified in nine patients (14.8%). Deep myometrial invasion was significantly associated with ITC/MM (p=0.028). ITC/MM was an independent risk factor for extrapelvic recurrence (hazard ratio, 17.9; 95% confidence interval [CI], 1.4 to 232.2). The 8-year overall survival (OS) and recurrence-free survival (RFS) rates were more than 20% lower in the ITC/MM group than in the node-negative group (OS, 71.4% vs. 91.9%; RFS, 55.6% vs. 84.0%), which were statistically not significant (OS, p=0.074; RFS, p=0.066). Time to recurrence tended to be longer in the ITC/MM group than in the node-negative group (median, 49 months vs. 16.5 months; p=0.080).ConclusionsIt remains unclear whether ITC/MM have an adverse influence on prognosis of intermediate-risk endometrial cancer. A multicenter cooperative study is needed to clarify the clinical significance of ITC/MM. |
| |
Keywords: | Endometrial Neoplasms Neoplasm Micrometastasis Neoplasm Recurrence Local Neoplasm Staging Retrospective Studies |
|
|